In particular, the estrogen receptor-alpha (ERα) (ESR1) - present in tumor cells of about 70% to 75% of all breast tumors - is considered crucial because of its proliferation-inducing actions and for that reason is an important target for therapy. This evidence concerns the gene ESR1 and neoplasm.